Information Library

Get to market faster

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • Re-energizing a Brand

    September 1, 2010
    Learn how Quintiles revamped the consumer marketing plan for an oral health product, boosting brand awareness by 90% and expanding the overall market size.

  • Biomarkers as an Approach to Improving Productivity in Oncology Drug Development

    August 19, 2010
    Richard Gaynor, MD of Eli Lilly presents Biomarkers as an Approach to Improving Productivity in Oncology Drug Development

  • Regulatory Opportunities

    August 13, 2010
    John Smyth, MD of the University of Edinburgh presents on Regulatory Opportunities.

  • New Pilot Examples Exploring these Novel Approaches

    August 13, 2010
    King Jolly, PharmD of Quintiles discusses New Pilot Examples Exploring these Novel Approaches

  • A Blueprint for Clinical/Commercial Convergence

    August 5, 2010
    The development model for bio pharmaceutical companies must shift from two divergent paths to one that combines these two resources with market access strategy, information and capabilities.

  • Syndicated Solutions

    June 30, 2010
    Astellas needed to rapidly ramp up its sales force by 50% to take advantage of a projected $1 billion opportunity. Quintiles provided a new risk.

  • ASCO Richard Gaynor

    June 21, 2010
    Biomarkers as an Approach to Improving Productivity

  • THE NEW HEALTH REPORT FINDS GREATER INFLUENCE FOR PATIENTS ON DRUG DEVELOPMENT

    June 15, 2010 - Patients are emerging as an increasingly strong group when it comes to influencing the success and failure of new drugs – according to a newly published New Health Report commissioned by Quintiles.

  • Defining Value

    June 8, 2010
    Market Access, one of the many Consulting services available from Quintiles, stands ready to help you navigate the value substantiation process, from developing and demonstrating your product’s value platform to winning a preferred position on payer formularies and negotiating pricing and reimbursement contracts.

  • The New Health

    May 26, 2010
    Quintiles examines the complex challenges and opportunities facing the bio pharmaceutical industry and how companies must manage risk, demonstrate greater value and improve patient outcomes.

Page 1 of 6 (53 results)

Subscribe to Email Based on Your Interests

Set preferences